Cardiac Arrhythmias

“Cardiac Arrhythmias” is an international peer-reviewed journal published under the auspices of the Eurasian Arrhythmological Association (EURA)

The purpose of the journal is to unite the efforts of arrhythmologists, cardiologists, cardiovascular surgeons and scientists of other specialties to improve the quality of medical care for patients with cardiac arrhythmias and conduction disorders. It is done through wide discussion of the results of scientific, practical, experimental, and fundamental works devoted to the issues of clinical arrhythmology, electrophysiology of the heart and related disciplines.

The journal publishes clinical guidelines, original articles, article reviews, clinical cases, lectures / reports, discussions on current medical problems associated with heart rhythm and conduction disorders, as well as notes on the activities of the Eurasian Arrhythmological Association.

The journal is published in Russian and English on a quarterly basis, both in electronic and printed versions. All translations of articles are carried out by the publisher and are free for the authors of the publication.

 

submit manuscript

Announcements More Announcements...

 
No announcements have been published.

Current Issue

Vol 3, No 3 (2023)

Original Research

Analysis of the endocardial stage of treatment of tachyarhythmias after open interventions for atrial fibrillation. Experience of one center
Postol A.S., Antipov G.N., Ivanchenko A.V., Lyashenko V.V., Kalinin D.A., Kotov S.N., Vygovsky A.B., Shneider Y.A.
Abstract

AIM: To study EFI parameters and features of recurrent atrial tachyarrhythmias in patients who underwent surgical correction of AF.

MATERIALS AND METHODS: from January 2013 to December 2021, 447 combined interventions were performed to eliminate AF using the labyrinth-3 and left atrial labyrinth techniques with correction of CHD (congenital heart disease) and/or coronary artery disease.

Rhythm disturbances were detected in 57 (12.7%) patients at various follow-up periods. Endovascular interventions were performed in 39 patients. The average follow-up period after the endocardial stage was 34.37 (standard deviation 24.32) months. The median age of patients was 64 (58–67) years, 21 (54%) were men. The patients were divided into 2 groups: group 1 — after the classic biatrial (BA) labyrinth-3 — 23 (59%) patients, group 2 — after the left-atrial variant (LA) labyrinth-3 — 16 (41%) patients.

At the endocardial stage, electrophysiological studies (EFI) were performed to clarify the mechanism of arrhythmia, and ablation eliminated tachyarrhythmia. EFI protocol: revision of the pulmonary veins, determination of the isolation of the posterior wall of the LA assessment of atrial arrhythmia, elimination of arrhythmia, control induction of arrhythmia after ablation. After repeated intervention, patients were observed in the operating clinic every 3 months.

RESULTS: After the endocardial stage, a regular rhythm was determined in 19 (82.6%) patients of the BA group, 13 (92.9%) patients of the LA group (p = 0.914). Relapses in the form of AF were noted in 5 patients (4 — group 1 and 1 — group 2) group (p = 0.306) All relapses of tachyarrhythmia with an irregular cycle (AF) were detected in patients with AF before the endovascular stage In both groups, there were cases of restoration of conduction in the pulmonary veins — 10 (43.5%) patients after BA ablation and 1 (5.3%) patient after LA ablation. There are no recurrences of atrial arrhythmia after ablation of atrial flutter (arrhythmia with a stable cycle).

CONCLUSION: The endocardial stage is highly effective and demonstrates subsequent freedom from atrial arrhythmia in patients who have tachycardia with a regular cycle after both methods of surgical ablation of AF. Recurrent tachyarrhythmia in the form of AF (irregular cycle) is associated with a low probability of maintaining a regular atrial rhythm after a repeated endocardial procedure, due to the presence of structural and electrophysiological changes in the atrial myocardium.

Cardiac Arrhythmias. 2023;3(3):5-18
pages 5-18 views

Case reports

Atrial fibrillation in a patient with diffuse myocardial fibrosis and mitral annular disjunction
Evdokimova L.S., Itskovich I.E., Novikova T.N., Garpinchenko T.V.
Abstract

A case of atrial fibrillation and premature ventricular complexes (PVC) in a patient with mitral valve prolapse and mitral annular disjunction is described. Rhythm disturbances occurred after a new coronavirus infection. Also, the patient has a history of combined treatment of left breast cancer, which contributed to the appearance of myocardial fibrosis as an arrhythmogenic substrate. Due to the ineffectiveness of conservative antiarrhythmic therapy, a radiofrequency catheter procedure was performed, which proved unsuccessful. The purpose of the article is to present the possible causes of cardiac arrhythmias and the role of magnetic resonance imaging in the diagnosis of arrhythmogenic myocardial fibrosis and mitral annular disjunction.

Cardiac Arrhythmias. 2023;3(3):19-26
pages 19-26 views
Clinical and genetic characterization of patients with catecholaminergic polymorphic ventricular tachycardia: a case series
Komissarova S.M., Rineiska N.M., Chakova N.N., Niyazova S.S., Plashchinskaya L.I., Barsukevich V.C., Podpalova O.V.
Abstract

AIM: of the study was to evaluate the clinical and genetic characteristics, including the development of adverse events and outcomes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).

MATERIALS AND METHODS: The clinical phenotype of eight patients with CPVT, two of whom were relatives of probands, was observed over 4 years. The clinical and instrumental study included ECG-12, 24-hour Holter ECG monitoring, genealogical history collection and family history of sudden cardiac death (SCD), transthoracic echocardiography and cardiac magnetic resonance imaging to detect structural myocardial changes, electrophysiologic study according to indications, and ICD monitoring. High-throughput sequencing (NGS) was utilized to search for mutations in genes linked to the onset of channelopathies and other inherited rhythm disorders.

RESULTS: In 8 patients, nucleotide variants of pathogenicity classes III-V were identified according to the ACMG (2015) criteria in the RYR2 gene associated with CPVT. Pathogenic (IV-V class) and likely pathogenic (IV class) mutations in the RYR2 gene were found in 6 (75%) probands, variants with uncertain clinical significance (VUS, class III) were found in 2 patients. At the time of diagnosis, transient QTc interval prolongation of more than 480 ms was detected in 4 (50%) patients; bradycardia less than 54 beats/min — in 2 (25%) patients, sequences of supraventricular tachycardia and ventricular tachyarrhythmia — in 2 (25%) patients. The most severe form of the disease with marked clinical manifestations and an episode of clinical death with subsequent resuscitation, as well as a transient QTc interval prolongation exceeding 500 ms was observed in patients with mutations c.11814C > A (p.Ser3938Arg, rs794728704); c.463G > A (p.Gly155Arg) and c.14876G > A (p.Arg4959Gln, rs794728811) in the RYR2 gene. Three (37.5%) patients underwent ICD implantation; one for primary SCD prevention and two for secondary prevention.

CONCLUSION: In this study, the spectrum of clinical manifestations in patients with genetically confirmed CPVT was examined. The findings highlight transient QTc interval extensions, significant sinus bradycardia, and sequences of supraventricular tachyarrhythmias, which can escalate into life-threatening ventricular tachyarrhythmias in CPVT patients.

Cardiac Arrhythmias. 2023;3(3):27-40
pages 27-40 views

Reviews

European guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 2022: cardiomyopathy. What’s new?
Novikova T.N., Bitakova F.I., Ignateva V.S., Novikov V.I., Sayganov S.A., Shcherbakova V.A.
Abstract

The review provides information on new indications that should be guiden the diagnosis and treatment of ventricular arrhythmias in patients with cardiomyopathy. The analysis of modern definitions and classifications of cardiomyopathy is given. The issues of ventricular arrhythmias in different cardiomyopathy phenotypes, risk stratification of sudden cardiac death and its prevention are considered in detail.

Cardiac Arrhythmias. 2023;3(3):41-62
pages 41-62 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies